LBIO Insider Trading Activity and SEC Form 4 Filings
LBIO insider trading summary
No open-market insider purchases or sales of Lion Biotechnologies, Inc. (LBIO) have been reported on SEC Form 4 in the past 12 months.
Latest LBIO insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 22, 2016 | Sanford Hillsberg | Director | Sell | $492K (54,000 @ $9.11) |
| Sep 8, 2015 | Sanford Hillsberg | Director | Sell | $118K (16,500 @ $7.13) |
| Sep 4, 2015 | Sanford Hillsberg | Director | Sell | $109K (16,000 @ $6.84) |
| Aug 3, 2015 | Sanford Hillsberg | Director | Sell | $265K (32,500 @ $8.15) |
| May 6, 2015 | Sanford Hillsberg | Director | Sell | $500K (50,000 @ $10.00) |
| May 1, 2015 | Ayer Capital Management, LP | 10% Owner | Sell | $26.8M (2,780,682 @ $9.62) |
| May 1, 2015 | ACM Capital Partners, LLC | 10% Owner | Sell | $26.8M (2,780,682 @ $9.62) |
| May 1, 2015 | Ayer Capital Partners, LLC | 10% Owner | Sell | $26.8M (2,780,682 @ $9.62) |
| Nov 6, 2014 | Bristol Investment Fund Ltd | 10% Owner | Sell | $69.00B (100,000 @ $690000.00) |
| Nov 5, 2013 | Merrill A/ McPeak | Director | Buy | $100K (50,000 @ $2.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.